Axogen Announces New VP Of Operations And Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
The inducement awards were approved by the Compensation Committee of the Company's Board of Directors in accordance with Nasdaq Stock Market Listing Rule 5635 (c) (4).
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2024
ALACHUA, Fla. and TAMPA, Fla., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, ...
Axogen, Inc.: Axogen Announces New VP of Operations and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, ...
National Institute for Health and Care Excellence2d
Published guidance, NICE advice and quality standards
Cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy TA117 24 January 2007 24 January 2007 Methadone and buprenorphine ...